| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |